What is Fluidic Sciences?
Fluidic Sciences, established in 2013 as a spin-out from the University of Cambridge's Department of Chemistry, is a UK-based company specializing in the design, development, and manufacturing of innovative tools for protein characterization. Operating within the laboratory, medical, and consumer applications markets, the company leverages its deep scientific expertise to provide fast, convenient, and accurate solutions for analyzing proteins. Its formation as a university spin-out suggests a strong foundation in research and development, aiming to translate academic breakthroughs into commercial products.
How much funding has Fluidic Sciences raised?
Fluidic Sciences has raised a total of $40.3M across 3 funding rounds:
Series A
$2.4M
Series B
$6.9M
Unspecified
$31M
Series A (2015): $2.4M with participation from Parkwalk Advisors, DFJ Esprit, Cambridge Enterprise, and Amadeus Capital Partners
Series B (2016): $6.9M led by Parkwalk Advisors, Cambridge Enterprise, IQ Capital Partners, Draper Esprit, Cambridge Innovation Capital, and Amadeus Capital Partners
Unspecified (2018): $31M supported by Delin Ventures, Amadeus Capital Partners, BGF, Draper Esprit, and IQ Capital
Key Investors in Fluidic Sciences
Amadeus Capital Partners
Amadeus Capital Partners is a London-based global technology venture capital firm that invests in high-growth companies from seed to later stages across sectors such as artificial intelligence, digital health, cybersecurity, enterprise software, fintech, and deep tech.
IQ Capital Partners
IQ Capital is a venture capital firm investing in 'deep-tech' across sectors including machine learning, AI, robotics, and advanced engineering and materials. They focus on disruptive algorithms and companies capable of global market dominance.
Parkwalk Advisors
Parkwalk Advisors is a leading investor in university spinouts, focusing on deeptech innovations emerging from the UK's top universities. They provide funding, expertise, and networks to help these companies thrive across sectors like AI, Quantum Computing, HealthTech, and CleanTech.
What's next for Fluidic Sciences?
The substantial enterprise-level funding Fluidic Sciences has attracted indicates a mature stage of growth, likely focused on scaling operations, expanding market reach, and further developing its proprietary technology. The strategic nature of recent investments suggests a focus on partnerships or market penetration initiatives. Future developments will likely involve enhancing its product portfolio and solidifying its position as a leader in protein characterization tools, potentially exploring new applications or geographical markets.
See full Fluidic Sciences company page
